Jumia Technologies exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. While the company maintains strong top-line revenue growth of 34.4%, this is offset by a devastating ROE of -109.87% and a Price-to-Book ratio of 32.26, which suggests extreme overvaluation relative to its equity. The lack of a Graham Number or Intrinsic Value reflects the absence of positive earnings, making the stock a highly speculative play. Despite bullish analyst targets, the deterministic data points to a high-risk profile with significant capital erosion over the long term.